Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1961 Oct;40(10):1891–1899. doi: 10.1172/JCI104413

EXPERIMENTAL REACTIVATION OF SUBSIDING RHEUMATIC FEVER

Alvan R Feinstein 1,2, Mario Spagnuolo 1,2,*
PMCID: PMC290887  PMID: 13892069

Full text

PDF
1891

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. FEINSTEIN A. R., DI MASSA R. Prognostic significance of valvular involvement in acute rheumatic fever. N Engl J Med. 1959 May 14;260(20):1001–1007. doi: 10.1056/NEJM195905142602002. [DOI] [PubMed] [Google Scholar]
  2. FEINSTEIN A. R., SPAGNUOLO M., GILL F. A. The rebound phenomenon in acute rheumatic fever. I. Incidence and significance. Yale J Biol Med. 1961 Feb;33:259–278. [PMC free article] [PubMed] [Google Scholar]
  3. FEINSTEIN A. R., SPAGNUOLO M. The duration of activity in acute rheumatic fever. JAMA. 1961 Apr 1;175:1117–1119. doi: 10.1001/jama.1961.03040130001001. [DOI] [PubMed] [Google Scholar]
  4. FEINSTEIN A. R. Standards, stethoscopes, steroids and statistics. The problem of evaluating treatment in acute rheumatic fever. Pediatrics. 1961 May;27:819–828. [PubMed] [Google Scholar]
  5. HARRIS T. N., VANDEGRIFT H. N. Leukocytosis as a complication of prednisone therapy in rheumatic fever. Pediatrics. 1960 Jan;25:80–84. [PubMed] [Google Scholar]
  6. WERNER S. C. ACTH and cortisone therapy of acute nonsuppurative (subacute) thyroiditis. J Clin Endocrinol Metab. 1953 Nov;13(11):1332–1340. doi: 10.1210/jcem-13-11-1332. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES